CHN2
Aliases:
This biomarker is also known as:- chimerin (chimaerin) 2
- Beta-chimerin
- RHOGAP3
- beta-chimerin
- beta-chimaerin
- beta3-chimaerin
- Rho GTPase-activating protein 3
- RhoGAP3
- ARHGAP3
- CHN2-3
- rho-GTPase-activating protein 3
- BCH
- CHN2
Description…
From NCBI Gene: This gene encodes a guanosine triphosphate (GTP)-metabolizing protein that contains a phorbol-ester/diacylglycerol (DAG)-type zinc finger, a Rho-GAP domain, and an SH2 domain. The encoded protein translocates from the cytosol to the Golgi apparatus membrane upon binding by diacylglycerol (DAG). Activity of this protein is important in cell proliferation and migration, and expression changes in this gene have been detected in cancers. A mutation in this gene has also been associated with schizophrenia in men. Alternative transcript splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, May 2014]
Datasets
There are no datasets associated with this biomarker.
Attributes
| QA State: | Under Review |
|---|---|
| Type: | Gene |
| HGNC Name: | CHN2 |
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.